The incidence of HBV and HCV infection in Australian travelers to Asia

Douglas F Johnson; Irani Ratnam; Elizabeth Matchett; Linda Earnest-Silveria; Dale Christiansen; Karin Leder; Michael L Grayson; Joseph Torresi

doi:10.1111/jtm.12029

The incidence of HBV and HCV infection in Australian travelers to Asia

J Travel Med. 2013 May-Jun;20(3):203-5. doi: 10.1111/jtm.12029.

Authors

Douglas F Johnson¹, Irani Ratnam, Elizabeth Matchett, Linda Earnest-Silveria, Dale Christiansen, Karin Leder, Michael L Grayson, Joseph Torresi

Affiliation

¹ Department of Infectious Diseases, Austin Hospital, University of Melbourne, Heidelberg, Victoria, Australia.

PMID: 23577867
DOI: 10.1111/jtm.12029

Abstract

We analyzed paired pre- and post-travel sera in a cohort of Australian travelers to Asia and demonstrated the acquisition of hepatitis C virus (HCV) and hepatitis B virus (HBV) infection. The incidence density in nonimmune travelers for HCV infection was calculated as 1.8 infections per 10,000 traveler-days and for HBV infection 2.19 per 10,000 traveler-days.

Publication types

Multicenter Study
Research Support, Non-U.S. Gov't

MeSH terms

Adult
Australia / epidemiology
Cohort Studies
Female
Hepatitis B* / diagnosis
Hepatitis B* / epidemiology
Hepatitis C* / diagnosis
Hepatitis C* / epidemiology
Humans
Incidence
Male
Risk Factors
Serologic Tests
Time Factors
Travel*